Skip to content

prophylactic antibiotics on surgical site infections in elective laparoscopic cholecystectomy.

The role of prophylactic antibiotics on surgical site infections in elective laparoscopic cholecystectomy in patients with symptomatic gallstone.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180615040107N1
Enrollment
76
Registered
2019-02-07
Start date
2018-03-21
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical site infection. Infection following a procedure, not elsewhere classified

Interventions

Intervention 1: Intervention group: In the first group, an antibiotic, cefazolin (one dose of 1 gram), will receive intravenous half an hour before the operation and two doses (1 gram) after surgery f

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 75 Years

Inclusion criteria

Inclusion criteria: Patients with symptomatic gallstone Patients candidate for elective laparoscopic cholecystectomy Patient under 75 years old

Exclusion criteria

Exclusion criteria: Patients who received antibiotics in the few days before surgery Patients with CBD stone or cholecystitis Patients with a history of diabetes Patients with using drugs that affect the immune system

Design outcomes

Primary

MeasureTime frame
Surgical site infection involves redness and swelling of the wound or purulent discharge. Timepoint: 24 hours after surgery and 4 to 7, 10 to 15 and 30 days after surgery. Method of measurement: Clinical.

Secondary

MeasureTime frame
Respiratory infection. Timepoint: 24 to 72 hours after surgery. Method of measurement: Clinical.;Fever& chills. Timepoint: 24 to 72 hours after surgery. Method of measurement: Clinical.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmir Behzadi

Kerman University of Medical Sciences

amirbehzady.ab@gmail.com+98 31 3439 2049

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026